European project IMMODGEL
Local immunomodulation around implants by innovative hydrogel-based systems
The main objective of the European project IMMODGEL is to avoid the frequent adverse immune reactions following implant surgery. Such immune reactions will be reduced by means of an innovative system composed of chemical (hydrogel) and biological (immune system cells) elements. The design will be adjustable for any implant, medical device or transplant.
Furthermore, a diagnostic test will be developed to predict the patients´ specific immune responses to implant materials. The system´s chemical and physical properties will be modified accordingly to avoid implant rejection. IMMODGEL will for the first time allow implants to be personalised and to minimise adverse immune reactions.
The key innovation will be the development of IMMODGEL as a system that will significantly decrease the level and duration of implant induced inflammation besides optimising the healing phase upon implantation. Thus it will reduce the negative outcomes of implant surgery, relieve pain and reduce related medical costs in Europe.
SEZ is responsible for the administrative and financial project management, the dissemination of the project as well as for the communication and IPR management. As project coordinator SEZ also acts as an intermediary between the European Commission and the scientific partners and SMEs involved.
Project duration: 10/2013 – 09/2017
Countries involved: Czech Republic, Estonia, France, Germany, Great Britain, USA